Form 4: Repligen CEO Sells Stock Under 10b5-1 Plan

Repligen Corporation's CEO, Olivier Loeillot, has sold 3,832 shares of common stock for $140 per share as part of a pre-arranged 10b5-1 trading plan.

Summary

• Olivier Loeillot, Chief Executive Officer and Director of Repligen Corporation (RGEN), reported a transaction on April 21, 2026.
• The transaction involved the sale of 3,832 shares of common stock.
• The sale was executed at a price of $140 per share.
• This sale was conducted under a Rule 10b5-1 trading plan, which was adopted on August 19th, 2025.
• Following the transaction, Loeillot beneficially owns 54,246 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While an insider sale can be a negative signal, the execution under a pre-arranged 10b5-1 plan indicates it's not based on current, non-public information.

Negatives

• The CEO sold a portion of his holdings, which could be perceived negatively by the market, although it was executed under a pre-planned trading strategy.

Risks

• The sale of stock by a key executive, even under a 10b5-1 plan, can sometimes lead to negative market sentiment if not clearly communicated or if it represents a significant portion of their holdings.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding the company's future performance. It solely reports a past transaction.

Management Comments

• The sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on August 19th, 2025.

Industry Context

StockSavvy.ai notes that insider sales, particularly by CEOs, are common and often executed under pre-established 10b5-1 plans to diversify holdings or meet financial obligations. The key is that the plan was in place prior to the transaction, mitigating concerns about trading on material non-public information.

Stakeholder Impact

• Shareholders: May interpret the sale as a sign of reduced confidence, though the 10b5-1 plan mitigates this concern. The sale does not directly impact the company's operations or value.

Next Steps

• Monitor future Form 4 filings for any additional transactions by Olivier Loeillot or other insiders.
• Observe the company's stock performance and any related news or announcements.

Key Dates

Keywords

Repligen Corporation, RGEN, Olivier Loeillot, Form 4, Insider Trading, 10b5-1 Plan, Stock Sale, Beneficial Ownership, Securities Exchange Act